{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:53:32Z","timestamp":1793224412993,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["232300421189"],"award-info":[{"award-number":["232300421189"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Project of Technology Innovation Leading Talent in Central Plain, China","award":["No. 234200510003"],"award-info":[{"award-number":["No. 234200510003"]}]},{"name":"Open Program of International Joint Research Laboratory for Recombinant Pharmaceutical Protein Expression System of Henan","award":["KFKTYB202209"],"award-info":[{"award-number":["KFKTYB202209"]}]},{"name":"Shaanxi Provincial Key R&D International Cooperation Program","award":["2021KW-67"],"award-info":[{"award-number":["2021KW-67"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10549-024-07504-6","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T11:02:04Z","timestamp":1728903724000},"page":"405-418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["BAFF overexpression in triple-negative breast cancer promotes tumor growth by inducing IL-10-secreting regulatory B cells that suppress anti-tumor T cell responses"],"prefix":"10.1007","volume":"209","author":[{"given":"Zhuangwei","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baofeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"7504_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nri2572","volume":"9","author":"F Mackay","year":"2009","unstructured":"Mackay F, Schneider P (2009) Cracking the BAFF code. Nat Rev Immunol 9:491\u2013502. https:\/\/doi.org\/10.1038\/nri2572","journal-title":"Nat Rev Immunol"},{"key":"7504_CR2","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.3389\/fimmu.2018.02285","volume":"9","author":"CR Smulski","year":"2018","unstructured":"Smulski CR, Eibel H (2018) BAFF and BAFF-receptor in B Cell selection and survival. Front Immunol 9:2285. https:\/\/doi.org\/10.3389\/fimmu.2018.02285","journal-title":"Front Immunol"},{"key":"7504_CR3","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.it.2018.07.002","volume":"39","author":"E Meinl","year":"2018","unstructured":"Meinl E, Thaler FS, Lichtenthaler SF (2018) Shedding of BAFF\/APRIL receptors controls B cells. Trends Immunol 39:673\u2013676. https:\/\/doi.org\/10.1016\/j.it.2018.07.002","journal-title":"Trends Immunol"},{"key":"7504_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.cytogfr.2008.04.006","volume":"19","author":"F Mackay","year":"2008","unstructured":"Mackay F, Schneider P (2008) TACI, an enigmatic BAFF\/APRIL receptor, with new unappreciated biochemical and biological properties. Cytokine Growth Factor Rev 19:263\u2013276. https:\/\/doi.org\/10.1016\/j.cytogfr.2008.04.006","journal-title":"Cytokine Growth Factor Rev"},{"key":"7504_CR5","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.136417","author":"M Yarchoan","year":"2020","unstructured":"Yarchoan M, Ho WJ, Mohan A, Shah Y, Vithayathil T, Leatherman J, Dennison L, Zaidi N, Ganguly S, Woolman S, Cruz K, Armstrong TD, Jaffee EM (2020) Effects of B cell-activating factor on tumor immunity. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.136417","journal-title":"JCI Insight"},{"key":"7504_CR6","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fonc.2020.00827","volume":"10","author":"M Kampa","year":"2020","unstructured":"Kampa M, Notas G, Stathopoulos EN, Tsapis A, Castanas E (2020) The TNFSF Members APRIL and BAFF and their receptors TACI, BCMA, and BAFFR in oncology, with a special focus in breast cancer. Front Oncol 10:827. https:\/\/doi.org\/10.3389\/fonc.2020.00827","journal-title":"Front Oncol"},{"key":"7504_CR7","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3892\/ol.2021.12989","volume":"22","author":"M Warakomska","year":"2021","unstructured":"Warakomska M, Tynecka M, Lemancewicz D, Grubczak K, Dzieciol J, Moniuszko M, Eljaszewicz A, Bolkun L (2021) The effects of BAFF and APRIL signaling on non-small cell lung cancer cell proliferation and invasiveness. Oncol Lett 22:728. https:\/\/doi.org\/10.3892\/ol.2021.12989","journal-title":"Oncol Lett"},{"key":"7504_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3389\/fonc.2018.00301","volume":"8","author":"V Pelekanou","year":"2018","unstructured":"Pelekanou V, Notas G, Athanasouli P, Alexakis K, Kiagiadaki F, Peroulis N, Kalyvianaki K, Kampouri E, Polioudaki H, Theodoropoulos P, Tsapis A, Castanas E, Kampa M (2018) BCMA (TNFRSF17) induces APRIL and baff mediated breast cancer cell stemness. Front Oncol 8:301. https:\/\/doi.org\/10.3389\/fonc.2018.00301","journal-title":"Front Oncol"},{"key":"7504_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12882-015-0064-y","volume":"16","author":"N Zheng","year":"2015","unstructured":"Zheng N, Wang D, Ming H, Zhang H, Yu X (2015) BAFF promotes proliferation of human mesangial cells through interaction with BAFF-R. BMC Nephrol 16:72. https:\/\/doi.org\/10.1186\/s12882-015-0064-y","journal-title":"BMC Nephrol"},{"key":"7504_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1471-2407-8-76","volume":"8","author":"V Pelekanou","year":"2008","unstructured":"Pelekanou V, Kampa M, Kafousi M, Darivianaki K, Sanidas E, Tsiftsis DD, Stathopoulos EN, Tsapis A, Castanas E (2008) Expression of TNF-superfamily members BAFF and APRIL in breast cancer: immunohistochemical study in 52 invasive ductal breast carcinomas. BMC Cancer 8:76. https:\/\/doi.org\/10.1186\/1471-2407-8-76","journal-title":"BMC Cancer"},{"key":"7504_CR11","doi-asserted-by":"publisher","first-page":"154790","DOI":"10.1016\/j.cyto.2019.154790","volume":"125","author":"MT Abo-Elfadl","year":"2020","unstructured":"Abo-Elfadl MT, Gamal-Eldeen AM, Ismail MF, Shahin NN (2020) Silencing of the cytokine receptor TNFRSF13B: a new therapeutic target for triple-negative breast cancer. Cytokine 125:154790. https:\/\/doi.org\/10.1016\/j.cyto.2019.154790","journal-title":"Cytokine"},{"key":"7504_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41467-021-27853-w","volume":"13","author":"DP Wong","year":"2022","unstructured":"Wong DP, Roy NK, Zhang K, Anukanth A, Asthana A, Shirkey-Son NJ, Dunmire S, Jones BJ, Lahr WS, Webber BR, Moriarity BS, Caimi P, Parameswaran R (2022) A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers. Nat Commun 13:217. https:\/\/doi.org\/10.1038\/s41467-021-27853-w","journal-title":"Nat Commun"},{"key":"7504_CR13","doi-asserted-by":"publisher","first-page":"e01047","DOI":"10.1002\/cti2.1047","volume":"8","author":"FB Vincent","year":"2019","unstructured":"Vincent FB, Kandane-Rathnayake R, Koelmeyer R, Hoi AY, Harris J, Mackay F, Morand EF (2019) Analysis of serum B cell-activating factor from the tumor necrosis factor family (BAFF) and its soluble receptors in systemic lupus erythematosus. Clin Transl Immunology 8:e01047. https:\/\/doi.org\/10.1002\/cti2.1047","journal-title":"Clin Transl Immunology"},{"key":"7504_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1189\/jlb.1209787","volume":"89","author":"HA Kim","year":"2011","unstructured":"Kim HA, Seo GY, Kim PH (2011) Macrophage-derived BAFF induces AID expression through the p38MAPK\/CREB and JNK\/AP-1 pathways. J Leukoc Biol 89:393\u2013398. https:\/\/doi.org\/10.1189\/jlb.1209787","journal-title":"J Leukoc Biol"},{"key":"7504_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1084\/jem.192.1.129","volume":"192","author":"JS Thompson","year":"2000","unstructured":"Thompson JS, Schneider P, Kalled SL, Wang L, Lefevre EA, Cachero TG, MacKay F, Bixler SA, Zafari M, Liu ZY, Woodcock SA, Qian F, Batten M, Madry C, Richard Y, Benjamin CD, Browning JL, Tsapis A, Tschopp J, Ambrose C (2000) BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J Exp Med 192:129\u2013135. https:\/\/doi.org\/10.1084\/jem.192.1.129","journal-title":"J Exp Med"},{"key":"7504_CR16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nri844","volume":"2","author":"F Mackay","year":"2002","unstructured":"Mackay F, Browning JL (2002) BAFF: a fundamental survival factor for B cells. Nat Rev Immunol 2:465\u2013475. https:\/\/doi.org\/10.1038\/nri844","journal-title":"Nat Rev Immunol"},{"key":"7504_CR17","doi-asserted-by":"publisher","first-page":"108796","DOI":"10.1016\/j.biopha.2019.108796","volume":"114","author":"S Hu","year":"2019","unstructured":"Hu S, Wang R, Zhang M, Liu K, Tao J, Tai Y, Zhou W, Wang Q, Wei W (2019) BAFF promotes T cell activation through the BAFF-BAFF-R-PI3K-Akt signaling pathway. Biomed Pharmacother 114:108796. https:\/\/doi.org\/10.1016\/j.biopha.2019.108796","journal-title":"Biomed Pharmacother"},{"key":"7504_CR18","doi-asserted-by":"publisher","first-page":"1235937","DOI":"10.3389\/fimmu.2023.1235937","volume":"14","author":"JA \u00c1lvarez G\u00f3mez","year":"2023","unstructured":"\u00c1lvarez G\u00f3mez JA, Salazar-Camarena DC, Rom\u00e1n-Fern\u00e1ndez IV, Ortiz-Lazareno PC, Cruz A, Mu\u00f1oz-Valle JF, Mar\u00edn-Rosales M, Espinoza-Garc\u00eda N, Sagrero-Fabela N, Palafox-S\u00e1nchez CA (2023) BAFF system expression in double negative 2, activated na\u00efve and activated memory B cells in systemic lupus erythematosus. Front Immunol 14:1235937. https:\/\/doi.org\/10.3389\/fimmu.2023.1235937","journal-title":"Front Immunol"},{"key":"7504_CR19","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS (2020) TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res 48:W509\u2013W514. https:\/\/doi.org\/10.1093\/nar\/gkaa407","journal-title":"Nucleic Acids Res"},{"key":"7504_CR20","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1016\/j.csbj.2021.07.014","volume":"19","author":"B Gy\u0151rffy","year":"2021","unstructured":"Gy\u0151rffy B (2021) Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer. Comput Struct Biotechnol J 19:4101\u20134109. https:\/\/doi.org\/10.1016\/j.csbj.2021.07.014","journal-title":"Comput Struct Biotechnol J"},{"key":"7504_CR21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","volume":"21","author":"S Jhunjhunwala","year":"2021","unstructured":"Jhunjhunwala S, Hammer C, Delamarre L (2021) Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat Rev Cancer 21:298\u2013312. https:\/\/doi.org\/10.1038\/s41568-021-00339-z","journal-title":"Nat Rev Cancer"},{"key":"7504_CR22","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/cmi.2017.35","volume":"14","author":"A Sarvaria","year":"2017","unstructured":"Sarvaria A, Madrigal JA, Saudemont A (2017) B cell regulation in cancer and anti-tumor immunity. Cell Mol Immunol 14:662\u2013674. https:\/\/doi.org\/10.1038\/cmi.2017.35","journal-title":"Cell Mol Immunol"},{"key":"7504_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40425-016-0145-x","volume":"4","author":"M Schwartz","year":"2016","unstructured":"Schwartz M, Zhang Y, Rosenblatt JD (2016) B cell regulation of the anti-tumor response and role in carcinogenesis. J Immunother Cancer 4:40. https:\/\/doi.org\/10.1186\/s40425-016-0145-x","journal-title":"J Immunother Cancer"},{"key":"7504_CR24","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1158\/2326-6066.CIR-20-0949","volume":"9","author":"K Wennhold","year":"2021","unstructured":"Wennhold K, Thelen M, Lehmann J, Schran S, Preugszat E, Garcia-Marquez M, Lechner A, Shimabukuro-Vornhagen A, Ercanoglu MS, Klein F, Thangarajah F, Eidt S, L\u00f6ser H, Bruns C, Quaas A, von Bergwelt-Baildon M, Schl\u00f6\u00dfer HA (2021) CD86(+) antigen-presenting B Cells are increased in cancer, localize in tertiary lymphoid structures, and induce specific T-cell responses. Cancer Immunol Res 9:1098\u20131108. https:\/\/doi.org\/10.1158\/2326-6066.CIR-20-0949","journal-title":"Cancer Immunol Res"},{"key":"7504_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000082105","volume":"8","author":"SL Kalled","year":"2005","unstructured":"Kalled SL, Ambrose C, Hsu YM (2005) The biochemistry and biology of BAFF, APRIL and their receptors. Curr Dir Autoimmun 8:206\u2013242. https:\/\/doi.org\/10.1159\/000082105","journal-title":"Curr Dir Autoimmun"},{"key":"7504_CR26","doi-asserted-by":"publisher","first-page":"e20220214","DOI":"10.1084\/jem.20220214","volume":"219","author":"YR Miao","year":"2022","unstructured":"Miao YR, Thakkar K, Cenik C, Jiang D, Mizuno K, Jia C, Li CG, Zhao H, Diep A, Xu Y, Zhang XE, Yang T, Liedtke M, Abidi P, Leung WS, Koong AC, Giaccia AJ (2022) Developing high-affinity decoy receptors to treat multiple myeloma and diffuse large B cell lymphoma. J Exp Med 219:e20220214. https:\/\/doi.org\/10.1084\/jem.20220214","journal-title":"J Exp Med"},{"key":"7504_CR27","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3390\/cancers15061791","volume":"15","author":"MA Ullah","year":"2023","unstructured":"Ullah MA, Mackay F (2023) The BAFF-APRIL system in cancer. Cancers (Basel) 15:1791. https:\/\/doi.org\/10.3390\/cancers15061791","journal-title":"Cancers (Basel)"},{"key":"7504_CR28","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1038\/ncomms6997","volume":"6","author":"AR Khan","year":"2015","unstructured":"Khan AR, Hams E, Floudas A, Sparwasser T, Weaver CT, Fallon PG (2015) PD-L1hi B cells are critical regulators of humoral immunity. Nat Commun 6:5997. https:\/\/doi.org\/10.1038\/ncomms6997","journal-title":"Nat Commun"},{"key":"7504_CR29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1158\/0008-5472.CAN-21-1171","volume":"82","author":"W Liu","year":"2022","unstructured":"Liu W, Stachura P, Xu HC, V\u00e1raljai R, Shinde P, Ganesh NU, Mack M, Van Lierop A, Huang A, Sundaram B, Lang KS, Picard D, Fischer U, Remke M, Homey B, Roesch A, H\u00e4ussinger D, Lang PA, Borkhardt A, Pandyra AA (2022) BAFF attenuates immunosuppressive monocytes in the melanoma tumor microenvironment. Cancer Res 82:264\u2013277. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-1171","journal-title":"Cancer Res"},{"key":"7504_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1365-2249.2009.04007.x","volume":"158","author":"I Moisini","year":"2009","unstructured":"Moisini I, Davidson A (2009) BAFF: a local and systemic target in autoimmune diseases. Clin Exp Immunol 158:155\u2013163. https:\/\/doi.org\/10.1111\/j.1365-2249.2009.04007.x","journal-title":"Clin Exp Immunol"},{"key":"7504_CR31","doi-asserted-by":"publisher","first-page":"8941260","DOI":"10.1155\/2016\/8941260","volume":"2016","author":"J Reiser","year":"2016","unstructured":"Reiser J, Banerjee A (2016) Effector, memory, and dysfunctional CD8(+) T cell fates in the antitumor immune response. J Immunol Res 2016:8941260. https:\/\/doi.org\/10.1155\/2016\/8941260","journal-title":"J Immunol Res"},{"key":"7504_CR32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","volume":"124","author":"H Raskov","year":"2021","unstructured":"Raskov H, Orhan A, Christensen JP, G\u00f6genur I (2021) Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy. Br J Cancer 124:359\u2013367. https:\/\/doi.org\/10.1038\/s41416-020-01048-4","journal-title":"Br J Cancer"},{"key":"7504_CR33","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/ijc.30169","volume":"139","author":"A Tang","year":"2016","unstructured":"Tang A, Dadaglio G, Oberkampf M, Di Carlo S, Peduto L, Laubreton D, Desrues B, Sun CM, Montagutelli X, Leclerc C (2016) B cells promote tumor progression in a mouse model of HPV-mediated cervical cancer. Int J Cancer 139:1358\u20131371. https:\/\/doi.org\/10.1002\/ijc.30169","journal-title":"Int J Cancer"},{"key":"7504_CR34","doi-asserted-by":"publisher","first-page":"830606","DOI":"10.3389\/fimmu.2022.830606","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Du H, Zhan S, Liu W, Wang Z, Lan J, PuYang L, Wan Y, Qu Q, Wang S, Yang Y, Wang Q, Xie F (2022) The interaction between the soluble programmed death ligand-1 (sPD-L1) and PD-1(+) regulator B cells mediates immunosuppression in triple-negative breast cancer. Front Immunol 13:830606. https:\/\/doi.org\/10.3389\/fimmu.2022.830606","journal-title":"Front Immunol"},{"key":"7504_CR35","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.4049\/jimmunol.0902551","volume":"184","author":"M Yang","year":"2010","unstructured":"Yang M, Sun L, Wang S, Ko KH, Xu H, Zheng BJ, Cao X, Lu L (2010) Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J Immunol 184:3321\u20133325. https:\/\/doi.org\/10.4049\/jimmunol.0902551","journal-title":"J Immunol"},{"key":"7504_CR36","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1158\/2326-6066.CIR-13-0214","volume":"2","author":"M Oft","year":"2014","unstructured":"Oft M (2014) IL-10: master switch from tumor-promoting inflammation to antitumor immunity. Cancer Immunol Res 2:194\u2013199. https:\/\/doi.org\/10.1158\/2326-6066.CIR-13-0214","journal-title":"Cancer Immunol Res"},{"key":"7504_CR37","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.ccell.2018.10.007","volume":"34","author":"A Naing","year":"2018","unstructured":"Naing A, Infante JR, Papadopoulos KP, Chan IH, Shen C, Ratti NP, Rojo B, Autio KA, Wong DJ, Patel MR, Ott PA, Falchook GS, Pant S, Hung A, Pekarek KL, Wu V, Adamow M, McCauley S, Mumm JB, Wong P, Van Vlasselaer P, Leveque J, Tannir NM, Oft M (2018) PEGylated IL-10 (Pegilodecakin) induces systemic immune activation, CD8+ T cell invigoration and polyclonal T cell expansion in cancer patients. Cancer Cell 34:775-791.e3. https:\/\/doi.org\/10.1016\/j.ccell.2018.10.007","journal-title":"Cancer Cell"},{"key":"7504_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11912-019-0760-z","volume":"21","author":"K Autio","year":"2019","unstructured":"Autio K, Oft M (2019) Pegylated interleukin-10: clinical development of an immunoregulatory cytokine for use in cancer therapeutics. Curr Oncol Rep 21:19. https:\/\/doi.org\/10.1007\/s11912-019-0760-z","journal-title":"Curr Oncol Rep"},{"key":"7504_CR39","doi-asserted-by":"publisher","first-page":"205031212110690","DOI":"10.1177\/20503121211069012","volume":"10","author":"B Mirlekar","year":"2022","unstructured":"Mirlekar B (2022) Tumor promoting roles of IL-10, TGF-\u03b2, IL-4, and IL-35: Its implications in cancer immunotherapy. SAGE Open Med 10:20503121211069012. https:\/\/doi.org\/10.1177\/20503121211069012","journal-title":"SAGE Open Med"},{"key":"7504_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.canlet.2015.07.009","volume":"367","author":"MH Mannino","year":"2015","unstructured":"Mannino MH, Zhu Z, Xiao H, Bai Q, Wakefield MR, Fang Y (2015) The paradoxical role of IL-10 in immunity and cancer. Cancer Lett 367:103\u2013107. https:\/\/doi.org\/10.1016\/j.canlet.2015.07.009","journal-title":"Cancer Lett"},{"key":"7504_CR41","doi-asserted-by":"publisher","first-page":"e1413520","DOI":"10.1080\/2162402X.2017.1413520","volume":"7","author":"M Shen","year":"2018","unstructured":"Shen M, Wang J, Yu W, Zhang C, Liu M, Wang K, Yang L, Wei F, Wang SE, Sun Q, Ren X (2018) A novel MDSC-induced PD-1(-)PD-L1(+) B-cell subset in breast tumor microenvironment possesses immuno-suppressive properties. Oncoimmunology 7:e1413520. https:\/\/doi.org\/10.1080\/2162402X.2017.1413520","journal-title":"Oncoimmunology"},{"key":"7504_CR42","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.4049\/jimmunol.1201920","volume":"190","author":"K Wejksza","year":"2013","unstructured":"Wejksza K, Lee-Chang C, Bodogai M, Bonzo J, Gonzalez FJ, Lehrmann E, Becker K, Biragyn A (2013) Cancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator-activated receptor \u03b1. J Immunol 190:2575\u20132584. https:\/\/doi.org\/10.4049\/jimmunol.1201920","journal-title":"J Immunol"},{"key":"7504_CR43","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ccell.2023.02.017","volume":"41","author":"CM Laumont","year":"2023","unstructured":"Laumont CM, Nelson BH (2023) B cells in the tumor microenvironment: multi-faceted organizers, regulators, and effectors of anti-tumor immunity. Cancer Cell 41:466\u2013489. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.017","journal-title":"Cancer Cell"},{"key":"7504_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11090906","author":"CL Tsai","year":"2021","unstructured":"Tsai CL, Lin CY, Chao A, Lee YS, Wu RC, Tsai CN, Yen CF, Chao AS (2021) GPR30 activation by 17\u03b2-estradiol promotes p62 phosphorylation and increases estrogen receptor \u03b1 protein expression by inducing its release from a complex formed with KEAP1. J Pers Med. https:\/\/doi.org\/10.3390\/jpm11090906","journal-title":"J Pers Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07504-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-024-07504-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07504-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T20:21:59Z","timestamp":1738354919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-024-07504-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["7504"],"URL":"https:\/\/doi.org\/10.1007\/s10549-024-07504-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"assertion":[{"value":"23 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All mice experiments were approved by and performed in accordance with national and regional guidelines and approved by the Institutional Animal Care and Use Committee (Approval Number: 2023-086.).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}